Utah Medical Products 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Kevin Cornwell

최고 경영자

US$510.6k

총 보상

CEO 급여 비율	29.8%
CEO 임기	31.9yrs
CEO 소유권	5.6%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	27.3yrs

최근 관리 업데이트

Recent updates

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30

Utah Medical Products declares $0.285 dividend

Nov 03

CEO 보상 분석

Kevin Cornwell 의 보수는 Utah Medical Products 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	US$15m
Jun 30 2024	n/a	n/a	US$16m
Mar 31 2024	n/a	n/a	US$16m
Dec 31 2023	US$511k	US$152k	US$17m
Sep 30 2023	n/a	n/a	US$17m
Jun 30 2023	n/a	n/a	US$17m
Mar 31 2023	n/a	n/a	US$17m
Dec 31 2022	US$452k	US$84k	US$16m
Sep 30 2022	n/a	n/a	US$16m
Jun 30 2022	n/a	n/a	US$16m
Mar 31 2022	n/a	n/a	US$15m
Dec 31 2021	US$494k	US$156k	US$15m
Sep 30 2021	n/a	n/a	US$14m
Jun 30 2021	n/a	n/a	US$13m
Mar 31 2021	n/a	n/a	US$11m
Dec 31 2020	US$327k	US$78k	US$11m
Sep 30 2020	n/a	n/a	US$12m
Jun 30 2020	n/a	n/a	US$13m
Mar 31 2020	n/a	n/a	US$15m
Dec 31 2019	US$474k	US$156k	US$15m
Sep 30 2019	n/a	n/a	US$14m
Jun 30 2019	n/a	n/a	US$17m
Mar 31 2019	n/a	n/a	US$18m
Dec 31 2018	US$501k	US$156k	US$19m
Sep 30 2018	n/a	n/a	US$13m
Jun 30 2018	n/a	n/a	US$10m
Mar 31 2018	n/a	n/a	US$9m
Dec 31 2017	US$501k	US$156k	US$9m

보상 대 시장: Kevin 의 총 보상 ($USD 510.57K ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 1.47M ).

보상과 수익: Kevin 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Kevin Cornwell (77 yo)

31.9yrs

테뉴어

US$510,570

보상

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Kevin Cornwell	Chairman	31.8yrs	US$510.57k	5.56% $ 12.1m
Paul Richins	Independent Director	26.8yrs	US$29.40k	0.63% $ 1.4m
Ernst Hoyer	Independent Lead Director	28.8yrs	US$37.80k	0.15% $ 320.9k
Barbara Payne	Independent Director	27.8yrs	US$29.40k	0.14% $ 310.5k
James Beeson	Independent Director	17.8yrs	US$29.40k	0.39% $ 842.4k
Carrie Leigh	Director	no data	데이터 없음	0.0015% $ 3.3k

27.3yrs

평균 재임 기간

77yo

평균 연령

경험이 풍부한 이사회: UTMD 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 27.3 년).

Utah Medical Products 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Utah Medical Products, Inc. Appoints Carrie Leigh to Its Board of Directors

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Chairman notifies of intention to sell stock

Independent Director recently sold US$65k worth of stock

Insufficient new directors

Independent Director recently sold US$170k worth of stock

Recent updates

Utah Medical Products, Inc. Appoints Carrie Leigh to Its Board of Directors

Third quarter 2024 earnings released: EPS: US$1.03 (vs US$1.08 in 3Q 2023)

Upcoming dividend of US$0.30 per share

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

Upcoming dividend of US$0.30 per share

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$1.09 (vs US$1.16 in 1Q 2023)

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Full year 2023 earnings released: EPS: US$4.58 (vs US$4.53 in FY 2022)

Utah Medical Products: An Attractive, But Speculative, Prospect

Upcoming dividend of US$0.30 per share

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Fourth quarter dividend of US$0.30 announced

Full year 2023 earnings released: EPS: US$4.57 (vs US$4.53 in FY 2022)

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 1.5% yield

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Third quarter 2023 earnings released: EPS: US$1.08 (vs US$1.18 in 3Q 2022)

Upcoming dividend of US$0.29 per share at 1.3% yield

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023

Second quarter 2023 earnings released: EPS: US$1.15 (vs US$1.13 in 2Q 2022)

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.29 per share at 1.2% yield

Independent Director recently sold US$65k worth of stock

Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023

Full year 2022 earnings released

Now 22% undervalued after recent price drop

Upcoming dividend of US$0.29 per share at 1.3% yield

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023

Now 21% undervalued

Full year 2022 earnings released: EPS: US$4.52 (vs US$4.06 in FY 2021)

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Upcoming dividend of US$0.29 per share

Investor sentiment improved over the past week

Insufficient new directors

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on January 4, 2023

Third quarter 2022 earnings released: EPS: US$1.18 (vs US$1.15 in 3Q 2021)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Second quarter 2022 earnings released: EPS: US$1.12 (vs US$0.94 in 2Q 2021)

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Independent Director recently sold US$170k worth of stock

Independent Director notifies of intention to sell stock

First quarter 2022 earnings released

Insufficient new directors

Utah Medical Products, Inc., Annual General Meeting, May 06, 2022

Full year 2021 earnings released: EPS: US$4.06 (vs US$2.95 in FY 2020)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Inaugural dividend of US$2.00 per share

Independent Director notifies of intention to sell stock

Independent Director recently sold US$222k worth of stock

Third quarter 2021 earnings released: EPS US$1.15 (vs US$0.81 in 3Q 2020)

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Upcoming dividend of US$0.28 per share

Independent Director recently sold US$176k worth of stock